Clinical trial / 2018
Foxtail millet intake was followed by reduced blood glucose in impaired glucose tolerance
In a self-controlled clinical study, adults with impaired glucose tolerance consumed 50 g daily of foxtail millet for 12 weeks. Following the intervention, fasting blood glucose dropped from 5.7 ± 0.9 mmol/L to 5.3 ± 0.7 mmol/L (p < 0.001) and 2-hour glucose fell from 10.2 ± 2.6 mmol/L to 9.4 ± 2.3 mmol/L (p = 0.003). Circulating leptin increased (p = 0.012) while insulin resistance declined (p = 0.007).
- Study type
- Self-controlled clinical trial
- Who was studied
- Adults with impaired glucose tolerance
- What was measured
- Fasting and 2-hour blood glucose, leptin, and insulin resistance
THE PAPER
The Glucose-Lowering Effect of Foxtail Millet in Subjects with Impaired Glucose Tolerance: A Self-Controlled Clinical Trial.
Ren X, Yin R, Hou D, Xue Y, Zhang M, Diao X, Zhang Y, Wu J, Hu J, Hu X, Shen Q. Nutrients, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.